Culturally safe, appropriate, and high-quality breast cancer screening for transgender people: A scoping review

Ramsey, Imogen; Kennedy, Kate; Sharplin, Greg; Eckert, Marion; Peters, Micah D J

doi:10.1080/26895269.2022.2155289

International Journal of Transgender Health

2023

DOI: 10.1080/26895269.2022.2155289

|View full text |Cite

Culturally safe, appropriate, and high-quality breast cancer screening for transgender people: A scoping review

Imogen Ramsey

Kate Kennedy

Greg Sharplin

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 75 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To date, insufficient information has been provided to transgenders regarding breast cancer, and it is hypothesized that the awareness of transgender people regarding breast cancer is low (3). Furthermore, financial problems, lack of access to care, discrimination, and fear of acceptance by society and medical staff might be barriers to breast cancer screening and diagnosis in the transgender population (4)(5)(6). Therefore, understanding the unique challenges faced by transgender individuals with breast cancer is crucial for providing appropriate care and developing comprehensive screening and management guidelines.…”

mentioning

confidence: 99%

Breast Cancer in Transgender Individuals: Challenges and Perspectives

Dashti,

Jafarzadeh Esfehani,

Tabriz Nia Tabrizi

2023

Mod Care J

View full text Add to dashboard Cite

Breast cancer is a complex and multidimensional disease affecting millions globally. While breast cancer is traditionally associated with cisgender women, it can also occur in transgender individuals (1). Hormone therapy, including estrogen and testosterone administration, might be a component of gender transition among transgender individuals and may, therefore, impact the risk of developing breast cancer (2).

show abstract

mentioning

confidence: 99%

Breast Cancer in Transgender Individuals: Challenges and Perspectives

Dashti,

Jafarzadeh Esfehani,

Tabriz Nia Tabrizi

2023

Mod Care J

View full text Add to dashboard Cite

show abstract

Gynecologic Oncology Needs for Trans-Masculine and Trans Feminine Persons

Rimel,

Murphy

2024

Curr Obstet Gynecol Rep

View full text Add to dashboard Cite

Purpose of the Review Persons with gender identity that is not congruent with their sex assigned at birth have unique needs in relationship to gynecologic malignancy screening and treatment. Providers of gynecologic oncology care require knowledge of these specific concerns and inclusive practices to avoid under screening and offer evidence-based treatments. This review seeks to collate data on the most common clinical situations gynecologic oncology providers encounter. Recent Findings Transmasculine persons who have a cervix need access to appropriate prevention and screening for cervical cancer but may face obstacles to obtaining this care. Transfeminine persons may develop HPV infection of the neovagina but cancer development rare and prevention is largely unknown. Abnormal uterine bleeding in transmasculine persons either taking gender affirming hormone therapy or not can present a diagnostic challenge which requires careful consideration to rule out malignancy. Concerns about testosterone use and the relationship of androgen receptor to ovarian cancer progression have been raised but conclusive data is lacking. There are no effective strategies for ovarian cancer screening and unnecessary exams should be avoided. Summary Large population based studies are needed to develop evidence based HPV screening guidelines that align with reproductive organ inventories, rather than gender or simply sex assigned at birth. HPV vaccination, utilization of HPV self swab in those for whom pelvic examination is dysphoric and careful evaluation of neovaginal tissue are first steps in reducing HPV related cancer burden. In addition, providers need to carefully evaluate abnormal uterine bleeding in transmasculine persons in gender inclusive ways to adequately detect endometrial pathology. Androgen receptor presence on ovarian cancer remains a biologic concern for transmasculine persons on gender affirming hormone therapy but risk of ovarian cancer appears small. Further long term studies of testosterone hormone therapy in this population are needed.

show abstract

Cancer Screening and Prevention in the Transgender and Gender Diverse Population: Considerations and Strategies for Advanced Practice Nurses

Ziegler,

Slotnes-O'Brien,

Peters

2024

Seminars in Oncology Nursing

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Culturally safe, appropriate, and high-quality breast cancer screening for transgender people: A scoping review

Cited by 5 publications

References 75 publications

Breast Cancer in Transgender Individuals: Challenges and Perspectives

Breast Cancer in Transgender Individuals: Challenges and Perspectives

Gynecologic Oncology Needs for Trans-Masculine and Trans Feminine Persons

Cancer Screening and Prevention in the Transgender and Gender Diverse Population: Considerations and Strategies for Advanced Practice Nurses

Contact Info

Product

Resources

About